Genes in schizoaffective disorder
Part of Brain & nervous system, Mental health clinical trials.
This study looks at two genes, LRFN5 and OLFM4, in people with schizoaffective disorder. Researchers want to see if these genes are different compared to healthy people. You may be asked to give a blood sample.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with schizoaffective disorder (according to the DSM-5-TR).
- You are currently having a manic episode.
- You have not taken any psychiatric medication for at least one month before the study.
- You are 18 to 64 years old.
- You do not have conditions like high blood pressure, diabetes, kidney disease, rheumatoid arthritis, lupus, heart disease, or severe neurological issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study builds a database of brain-signal measurements to help find “biomarkers” that may point to schizophrenia or related mental illnesses. Depending on whether you have a mental health diagnosis or you’re healthy, the study will collect information and brain data to compare groups.
This study looks at two blood proteins (LRFN5 and OLFM4) in people with methamphetamine use disorder or methamphetamine-induced psychosis, compared to healthy controls. Results may help understand the biology of these conditions.
This research study examines how certain genes are expressed (turned on or off) in people with psychiatric conditions like bipolar disorder, depression, panic disorder, OCD, or schizophrenia. The study compares gene expression in patients with these conditions to healthy volunteers to better understand what happens at a biological level.
This study collects information about mental health symptoms and body/genetic samples to better understand how different mental health conditions are related. Some people may also have brain scans (PET or MRI) if they can safely complete them.
This study looks at how the immune system, genetics, inflammation, and past exposures may relate to bipolar disorder or schizophrenia. It may help researchers understand the cause and find better ways to support people with these conditions.
This study tests whether using brain scans and genetic tests can help choose the best treatment for people early in their schizophrenia. It will check if these biomarkers can predict who will respond better to medication.
Hear when a new Schizoaffective Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.